Methylation-Mediated Silencing of MicroRNA-211 Decreases the Sensitivity of Melanoma Cells to Cisplatin

BACKGROUND: Malignant melanoma is recalcitrant to most existing chemotherapies, and aberrant expression of miR-211 plays prominent roles in progression of melanoma. However, the trigger mechanism of aberrant miR-211 expression in melanoma is still elusive. MATERIAL/METHODS: We used qRT-PCR to test m...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ning, Liu, Ying, Pang, Hao, Lee, Daeshin, Zhou, Yongting, Xiao, Zhibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2019
Materias:
Animal Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407329/
https://www.ncbi.nlm.nih.gov/pubmed/30821276
http://dx.doi.org/10.12659/MSM.911862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407329/
https://www.ncbi.nlm.nih.gov/pubmed/30821276
http://dx.doi.org/10.12659/MSM.911862

Ejemplares similares